Anna V. Polikarpova
Sochi, KDA 354340, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
AAV Vector Toolkit for the Delivery and Expression of the Artificial microRNA in the Murine Heart.
Journal: Biotech (Basel (Switzerland))
Published: May 18, 2026
VBIT-4 Rescues Mitochondrial Dysfunction and Reduces Skeletal Muscle Degeneration in a Severe Model of Duchenne Muscular Dystrophy.
Journal: International journal of molecular sciences
Published: August 18, 2025
RNA Interference Effectors Selectively Silence the Pathogenic Variant GNAO1 c.607 G > A In Vitro.
Journal: Nucleic acid therapeutics
Published: January 12, 2024
In-Frame Deletion of Dystrophin Exons 8-50 Results in DMD Phenotype.
Journal: International journal of molecular sciences
Published: April 10, 2023
CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the Gnao1 for safety studies of RNA therapeutics.
Journal: Frontiers in genome editing
Published: September 01, 2022
CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein.
Journal: Molecular therapy. Methods & clinical development
Published: August 10, 2022
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression.
Journal: Scientific reports
Published: September 20, 2021
In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin.
Journal: Experimental cell research
Published: November 28, 2019
Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors.
Journal: Steroids
Published: October 31, 2018
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene.
Journal: Disease models & mechanisms
Published: October 25, 2018
Last Updated: 09/26/2026